This is a business brief by JETRO released on August 15, 2025, regarding President Trump's strengthening of the pharmaceutical supply chain. President Trump issued an executive order aimed at securing strategic stockpiles of pharmaceutical active pharmaceutical ingredients (APIs), clarifying his policy to strengthen America's pharmaceutical supply security.
This executive order will advance the establishment of domestic production systems for critical pharmaceutical APIs and expansion of strategic stockpiles, with the aim of reducing dependence on overseas sources such as China. The pharmaceutical industry will be required to review production systems and expand investments.